| When are research risks reasonable in relation to anticipated benefits? C Weijer, PB Miller Nature medicine 10 (6), 570-573, 2004 | 241 | 2004 |
| A theory of fiduciary liability PB Miller McGill LJ 56, 235, 2010 | 203 | 2010 |
| Fiduciary Governance PB Miller, AS Gold William & Mary Law Review, 2015 | 162* | 2015 |
| Justifying fiduciary duties PB Miller McGill Law Journal 58 (4), 969-1023, 2013 | 153 | 2013 |
| Rehabilitating equipoise PB Miller, C Weijer Kennedy Institute of Ethics Journal 13 (2), 93-118, 2003 | 145 | 2003 |
| Fiduciary obligation in clinical research PB Miller, C Weijer Journal of Law, Medicine & Ethics 34 (2), 424-440, 2006 | 114 | 2006 |
| The human subjects trade: Ethical and legal issues surrounding recruitment incentives T Lemmens, PB Miller Journal of Law, Medicine & Ethics 31 (3), 398-418, 2003 | 84 | 2003 |
| Justifying fiduciary remedies PB Miller University of Toronto Law Journal 63 (4), 570-623, 2013 | 80* | 2013 |
| Trust based obligations of the state and physician-researchers to patient-subjects PB Miller, C Weijer Journal of Medical Ethics 32 (9), 542-547, 2006 | 59 | 2006 |
| Protecting communities in pharmacogenetic and pharmacogenomic research C Weijer, PB Miller The pharmacogenomics journal 4 (1), 9-16, 2004 | 58 | 2004 |
| Philosophical foundations of fiduciary law AS Gold, PB Miller Oxford University Press, 2014 | 54 | 2014 |
| The fiduciary relationship PB Miller Forthcoming in: Andrew S. Gold & Paul B. Miller, eds., Philosophical …, 2013 | 47 | 2013 |
| Equipoise and the duty of care in clinical research: a philosophical response to our critics PB Miller, C Weijer The Journal of medicine and philosophy 32 (2), 117-133, 2007 | 43 | 2007 |
| Getting into Equity SL Bray, PB Miller Notre Dame L. Rev. 97, 1763, 2021 | 42 | 2021 |
| Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice T Lemmens, PB Miller The American Journal of Bioethics 2 (2), 14-17, 2002 | 37 | 2002 |
| Against Fiduciary Constitutionalism SL Bray, PB Miller Virginia Law Review 106 (7), 1479-1532, 2020 | 32 | 2020 |
| Refuting the net risks test: a response to Wendler and Miller’s “Assessing research risks systematically” C Weijer, PB Miller Journal of medical ethics 33 (8), 487-490, 2007 | 29 | 2007 |
| Therapeutic obligation in clinical research.(another voice) C Weijer, PB Miller The Hastings Center Report 33 (3), 3-4, 2003 | 26 | 2003 |
| Moral solutions in assessing research risk PB Miller, C Weijer IRB: Ethics & Human Research 22 (5), 6-10, 2000 | 20 | 2000 |
| The New Formalism in Private Law PB Miller The American Journal of Jurisprudence 66 (2), 175-238, 2021 | 17 | 2021 |
Charles WeijerProfessor of Medicine, Epidemiology & Biostatistics, and Philosophy, Western University在 uwo.ca 的电子邮件经过验证
